Patents by Inventor Marjorie Zettler

Marjorie Zettler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridoxal-5-Phosphate And Stent For The Treatment And Prevention Of Atherosclerosis And Restenosis
    Publication number: 20080175880
    Abstract: The present invention provides method of treating and preventing vascular inflammation, atherosclerosis, restenosis, plaque destabilization and bypass graft failure comprising the administration of a therapeutically effective amount of pyridoxal-5?-phosphate or a pharmaceutically acceptable salt thereof. The present invention further provides an intravascular stent for use with a narrowed artery having at least one surface reversibly bound with pyridoxal-5?-phosphate or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 26, 2005
    Publication date: July 24, 2008
    Applicant: MEIDCURE INTERNATIONAL INC.
    Inventor: Marjorie Zettler
  • Compounds and methods for regulating triglyceride levels
    Patent number: 7375112
    Abstract: The present invention provides a method of administering vitamin B6 related compounds for treatment of hypertriglyceridemia. Vitamin B6 related compounds include pyridoxal, pyridoxal-5?-phosphate, pyridoxamine, a 3-acylated analogue of pyridoxal, a 3-acylated analogue of pyridoxal-4,5-aminal, and mixtures thereof. Embodiments of the present invention also comprise co-administering a lipid lowering agent, such as a nicotinic acid, a fibrate, a HMG CoA reductase inhibitor, a cholesteryl ester transfer protein inhibitor, and combinations thereof.
    Type: Grant
    Filed: January 5, 2006
    Date of Patent: May 20, 2008
    Assignee: Medicure International Inc.
    Inventors: Albert D. Friesen, Marjorie Zettler
  • Combination Therapies Employing Nicotinic Acid Derivatives or Fibric Acid Derivatives
    Publication number: 20080032952
    Abstract: The present invention provides pharmaceutical compositions comprising a nicotinic acid derivative or a fibric acid derivative and a pyridoxal-5?-phosphate or a pyridoxal-5?-phosphate related compound and methods for using pharmaceutical compositions for reducing the risk of cardiovascular and other diseases.
    Type: Application
    Filed: July 11, 2005
    Publication date: February 7, 2008
    Inventors: Marjorie Zettler, Ahmad Khalil
  • Combination Therapies Employing A Composition Comprising A Hmg Coa Reductase Inhibitor And A Vitamin B6 Related Compound
    Publication number: 20070280915
    Abstract: The present invention provides pharmaceutical compositions comprising a HMG CoA reductase inhibitor and a vitamin B6 related compound and methods for using the pharmaceutical compositions for reducing the risk of cardiovascular and other diseases.
    Type: Application
    Filed: December 23, 2004
    Publication date: December 6, 2007
    Applicant: Medicure International Inc.
    Inventors: Albert Friesen, Ahmad Khalil, Marjorie Zettler
  • Compounds and methods for regulating triglyceride levels
    Publication number: 20060148763
    Abstract: The present invention provides a method of administering vitamin B6 related compounds for treatment of hypertriglyceridemia. Vitamin B6 related compounds include pyridoxal, pyridoxal-5?-phosphate, pyridoxamine, a 3-acylated analogue of pyridoxal, a 3-acylated analogue of pyridoxal-4,5-aminal, and mixtures thereof. Embodiments of the present invention also comprise co-administering a lipid lowering agent, such as a nicotinic acid, a fibrate, a HMG CoA reductase inhibitor, a cholesteryl ester transfer protein inhibitor, and combinations thereof.
    Type: Application
    Filed: January 5, 2006
    Publication date: July 6, 2006
    Inventors: Albert Friesen, Marjorie Zettler